Table 4.

Effect of Jobelyn^® on monosodium glutamate-induced alterations of liver proteins in mice serum

Treatments groups	Bilurubin (mg/dL)	Albumin (g/dL)	Total protein (g/mL)
VEH (10 mL/kg)	0.23 ± 0.02	3.05 ± 0.13	6.59 ± 0.26
MSG (8 g/kg)	0.97 ± 0.02*	2.07 ± 0.04*	3.44 ± 0.24*
MSG (8 g/kg) + JB (5 mg/kg)	0.53 ± 0.02#	2.83 ± 0.10#	6.42 ± 0.27#
MSG (8 g/kg) + JB (10 mg/kg)	0.57 ± 0.02#	2.77 ± 0.19#	6.00 ± 0.38#
MSG (8 g/kg) + JB (20 mg/kg)	0.58 ± 0.30#	2.95 ± 0.15#	6.00 ± 0.04#

Values represents the mean ± SEM of grouped mice (n = 3). *p < 0.05 compared to vehicle group. ^#p < 0.05 compared to MSG (8 g/kg) (one-way ANOVA proceeded by Bonferroni post-hoc test)

VEH vehicle, MSG monosodium glutamate, JB Jobelyn^®